ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $212,649 | -47.1% | 10,702 | -54.4% | 0.02% | -38.9% |
Q1 2023 | $402,332 | -26.7% | 23,487 | -31.7% | 0.04% | -16.3% |
Q3 2022 | $549,000 | +123.2% | 34,397 | +92.0% | 0.04% | +115.0% |
Q2 2022 | $246,000 | -27.4% | 17,914 | -16.1% | 0.02% | -28.6% |
Q1 2022 | $339,000 | +15.7% | 21,347 | +59.0% | 0.03% | +7.7% |
Q4 2021 | $293,000 | -25.6% | 13,426 | +2.0% | 0.03% | -44.7% |
Q3 2021 | $394,000 | -16.3% | 13,167 | +23.7% | 0.05% | -34.7% |
Q2 2021 | $471,000 | +21.4% | 10,645 | +21.9% | 0.07% | -15.3% |
Q1 2021 | $388,000 | – | 8,736 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |